(1)
Giustolisi, R.; Fantozzi, N.; Staltari, M.; Marchiori, J.; Mastrangelo, O.; Marcucci, R.; Mirra, F.; Mazzotta, P.; Gabrieli, C. B.; The Luce Study Group. Combined Intravitreal Ranibizumab and Verteporfin Photodynamic Therapy Versus Ranibizumab Alone for the Treatment of Age-Related Macular Degeneration. Digit J Ophthalmol 2011, 17, 23-30.